Neuroprotective strategies against calpain-mediated neurodegeneration
Open Access
- 1 February 2015
- journal article
- review article
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. 11, 297-310
Abstract
Calpains are calcium-dependent proteolytic enzymes that have deleterious effects on neurons upon their pathological over-activation. According to the results of numerous studies to date, there is no doubt that abnormal calpain activation triggers activation and progression of apoptotic processes in neurodegeneration, leading to neuronal death. Thus, it is very crucial to unravel all the aspects of calpain-mediated neurodegeneration in order to protect neurons through eliminating or at least minimizing its lethal effects. Protecting neurons against calpain-activated apoptosis basically requires developing effective, reliable, and most importantly, therapeutically applicable approaches to succeed. From this aspect, the most significant studies focusing on preventing calpain-mediated neurodegeneration include blocking the N-methyl-d-aspartate (NMDA)-type glutamate receptor activities, which are closely related to calpain activation; directly inhibiting calpain itself via intrinsic or synthetic calpain inhibitors, or inhibiting its downstream processes; and utilizing the neuroprotectant steroid hormone estrogen and its receptors. In this review, the most remarkable neuroprotective strategies for calpain-mediated neurodegeneration are categorized and summarized with respect to their advantages and disadvantages over one another, in terms of their efficiency and applicability as a therapeutic regimen in the treatment of neurodegenerative diseases.Keywords
This publication has 115 references indexed in Scilit:
- Influence of the NR3A subunit on NMDA receptor functionsProgress in Neurobiology, 2010
- Calpain as a Therapeutic Target in Traumatic Brain InjuryNeurotherapeutics, 2010
- Extrasynaptic NMDA Receptors Couple Preferentially to Excitotoxicity via Calpain-Mediated Cleavage of STEPJournal of Neuroscience, 2009
- Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1α truncationExperimental Neurology, 2009
- Interactions between riluzole and ABCG2/BCRP transporterNeuroscience Letters, 2009
- Neuroprotective strategies targeting apoptotic and necrotic cell death for strokeApoptosis, 2009
- Marked Calpastatin (CAST) Depletion in Alzheimer's Disease Accelerates Cytoskeleton Disruption and Neurodegeneration: Neuroprotection by CAST OverexpressionJournal of Neuroscience, 2008
- Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer diseaseJournal of Clinical Investigation, 2008
- Biofunctionalized targeted nanoparticles for therapeutic applicationsExpert Opinion on Biological Therapy, 2008
- Inhibition of the proteolysis of rat erythrocyte membrane proteins by a synthetic inhibitor of calpainBiochemical and Biophysical Research Communications, 1988